Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Revenue (2019 - 2025)

Korro Bio's Revenue history spans 6 years, with the latest figure at $1.3 million for Q4 2025.

  • For the quarter ending Q4 2025, Revenue fell 43.11% year-over-year to $1.3 million, compared with a TTM value of $6.4 million through Dec 2025, up 181.46%, and an annual FY2025 reading of $6.4 million, up 181.46% over the prior year.
  • Revenue for Q4 2025 was $1.3 million at Korro Bio, up from $1.1 million in the prior quarter.
  • The five-year high for Revenue was $9.4 million in Q2 2021, with the low at -$284000.0 in Q1 2023.
  • Average Revenue over 4 years is $2.8 million, with a median of $1.9 million recorded in 2024.
  • Year-over-year, Revenue increased 10.49% in 2021 and then plummeted 43.11% in 2025.
  • Tracing KRRO's Revenue over 4 years: stood at $9.4 million in 2021, then crashed by 103.02% to -$284000.0 in 2023, then skyrocketed by 899.65% to $2.3 million in 2024, then plummeted by 43.11% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Revenue are $1.3 million (Q4 2025), $1.1 million (Q3 2025), and $1.5 million (Q2 2025).